Data dive could give PolyPid antibiotic a lifeline

Shares in PolyPid have been under pressure after the Israeli biotech reported its antibiotic for surgical site infections failed a phase 3 trial, although there may still be a way forward f

Boehringer backs AI-powered anti-infective startup ArrePath

A new company set up to use machine learning to find new anti-infective drugs – ArrePath – has launched onto the scene with $20 million in seed financing from a group of investors including

Roche’s Xofluza limits spread of flu virus, says new study

FDA reviewer backs Gilead’s Descovy for PrEP, but not in wom...

ViiV files monthly HIV jab in Europe